Thats true.
Waste of space.
Although the article was interesting, shows how busy MHC must be.
Thats probably not what he wanted to convey.
"'The decent British public will put up with it for as long as there is a threat. The alternative to PCR testing is closed borders.'
Are you suggesting COVID has come from nowhere and is now here to stay with humanity and be a threat to its existence forever?"
No
The decent British public will put up with it for as long as there is a threat. The alternative to PCR testing is closed borders.
There is no doubt that partnering with airlines would be a good strategy. But so is the Boots one. An even better strategy would be both.
Turkey, military, blah, blah, blah. You are just spouting complete excrement.
WE have a pretty good indicator of sales with the Related Party Transaction last week. £1.425m to EKF for PrimeStore® MTM sample collection devices. I don't know the unit cost of these but others are sub £1 list price, for that sort of order they should have negotiated a good discount. So, for £1 a collector thats £1.425m kits to be sold, at £2 its over 700k kits, at £5 is 285k kits. The best bit: "...will support the supply of the MyHealthChecked COVID-19 Sample Collection Kit to the market over the summer period as travel begins to ramp up." If the expectation is for this number of kits over the summer months then robbieishere is erring on the conservative side. DYOR, etc, etc.
Last year final results were released on the 29th May. I wouldn't be surprised if they leave it to the end of the month to be able to give a trading update 7 to 10 days after international travel is allowed. At which point, we should have some really promising numbers and potentially a re-rate in the sp. Not long to wait!
Are you invested here yet? Previously you said that you didn't understand this area so you weren't going to buy here. So, do you have any interest in this share? Or are you here just to spout irrelevant BS?
PAUL1DEANO - I don't follow your logic. If Turkey does not require a negative test upon entry to the country, thats up to the Turkish government. That has absolutely nothing to do with the requirements of the UK government.
Turkey is currently assessed as high risk, therefore are placed on the red list for travel by the UK government. So, it is illegal to travel there for the purpose of pleasure. If you had a compelling reason to go there, upon return to the UK you will have to follow the rules for passengers entering the UK from red list countries. As bakky says, this requires staying in a hotel for 10 days at a cost of £1750.
You may see it as persecuting tourists, I see it as protecting the citizens and the economy from further waves of COVID.
If you need to go somewhere, just go to Portugal!!!
Go to Turkey, but its a red list country. However:
You should not be travelling to red countries for leisure.
Forty-three countries are now on the red list, including Turkey, India, ****stan, Nepal, the Maldives, Brazil and South Africa.
People can only enter the UK if they are a UK or Irish national (or UK resident).
Travellers must:
Take a private Covid test before returning to England
Fill in a passenger locator form online before they head home
Book a 10-day hotel quarantine and testing package for each member of their group before departure
Take a private PCR test on or before day two of their arrival in England and again on day eight
Thats probably one of the reasons why Turkey isn't on the Green List...
The exclusive external contractor for Yourgene is also a very, very nice announcement - probably worthy of its own RNS!
Thats wise advice. Good luck with your investments.
No, it is not a false positive. A false positive is a positive result in the absence of the targeted antigen. The extract that you cut says that if you get a positive result it may be because of your historic infection, in which case you are not infectious, or, it could be due to a reinfection, in which case you are infectious. If you recieve a positive result then you should consult an infection specialist. If you recieve a negative result then happy days, you can travel.
This is clear in the bit that you did not paste from point 6. It says:
"If a person is re-tested by PCR within 90 days from their initial illness onset or test date and is found to still be positive for SARS-CoV-2, a clinically-led approach, taking into account several factors, should be used to decide whether re-infection is a possibility and to inform subsequent action. Such factors include:
COVID-19 symptoms
underlying clinical conditions
immunosuppressive treatments and conditions
additional information such as cycle threshold values
Seek advice from an infection specialist as required.
If a person is re-tested by PCR after 90 days from their initial illness onset or test and is found to be PCR positive, this should be considered as a possible new infection. If they have developed new COVID-19 symptoms, they would need to self-isolate again and their contacts should be traced."
That article is a deliberate misrepresentation of the facts, with a story purpetrated by a conspiracy theorist ex-GP, who denies the existence of AIDS. Yes, the test PCR tests do amplify COVID RNA, regardless of whether it is active or not, infectious or not. But it is by far the best test that is available. PCR testing is not going anywhere.
A downward spiral??? Two red days is hardly a spiral, especially in a volatile AIM market, during a global pandemic, with a recession and Brexit.
Bakky, I am sure that you have done your research into this company, therefore, I am sure that you will already know that MHC have a very close relationship with Abingdon Health, who would able to supply the other tests required for the contract.
However, I am not sure that the tender referred to below is the basis for the rumours.
The relationship is a lot closer than a standard supply relationship, you only have to look at the respective Boards of Directors to see that. MHC is effectively a B2C outlet for YGEN.
Under EIS, companies can raise up to £5m per year. The company raised £1.9m in April of last year, so they only had £3.1m that could be designated for EIS. My guess is that Mercia EIS required further assurance from HMRC that the newly issued shares would be eligible. The extract below is taken from the original RNS in which they were seeking £3m, which would have been within their allowance. I don't have a definitive answer, but that is my belief.
"EIS and VCT status
The following information is based upon the laws and practice currently in force in the UK and may not apply to persons who do not hold their Ordinary Shares as investments.
The Directors believe that the Placing Shares and Subscription Shares to be issued pursuant to the Fundraising will rank as "eligible shares" for the purposes of EIS and will be capable of being a "qualifying holding" for the purposes of investment by VCTs."
No, that is incorrect. Whilst the shares can be sold straight away, they would not be entitled to EIS relief. Therefore, its unlikely that these shares will be flipped by the VCT's or HNWI who are buying in the placing.